Hi Eason,
Thanks for your great research.
I completely absolutely agree with what you said. The strategic fit and market penetration offered by RB is underappreciated IMO. From a financial point of view I agree with you it may become a bigger earner than telehealth. From a utility point of view it's also a no-brainer. From a market positioning and strategic point of view I think having ResAppDx in the consumer space will drastically increase customer awareness around the world and force the hands of many telehealth providers to sign up.
ResApp Fundamentals & General Discussion, page-5
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #